Birdwatch Archive

Birdwatch Note

2023-07-04 13:08:49 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

O deputado mente. A Takeda ainda não enviou solicitação de incorporação do imunizante ao SUS e a adoção deste no Brasil "dependerá de critérios científicos, tecnológicos e do processo institucional definido em lei para garantir o acesso das pessoas em bases sustentáveis". https://www.gov.br/saude/pt-br/canais-de-atendimento/sala-de-imprensa/notas-a-imprensa/2023/sobre-a-materia-dengue-ministerio-da-saude-prioriza-produto-nacional-e-vacina-deve-ficar-para-2025

Written by B7A859BC93727E3BFBC5F28E0BB4C734821089390CEE6B553CD6EF225AA84119
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1676175075274309632

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1676216492994576387
  • noteId - 1676216492994576387
  • participantId -
  • noteAuthorParticipantId - B7A859BC93727E3BFBC5F28E0BB4C734821089390CEE6B553CD6EF225AA84119 Participant Details
  • createdAtMillis - 1688476129183
  • tweetId - 1676175075274309632
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 1
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • O deputado mente. A Takeda ainda não enviou solicitação de incorporação do imunizante ao SUS e a adoção deste no Brasil "dependerá de critérios científicos, tecnológicos e do processo institucional definido em lei para garantir o acesso das pessoas em bases sustentáveis". https://www.gov.br/saude/pt-br/canais-de-atendimento/sala-de-imprensa/notas-a-imprensa/2023/sobre-a-materia-dengue-ministerio-da-saude-prioriza-produto-nacional-e-vacina-deve-ficar-para-2025

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2023-07-04 13:08:49 UTC
(1688476129183)
1969-12-31 23:59:59 UTC
(-1)
2023-07-05 02:12:43 UTC
(1688523163429)
NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)

Note Ratings

rated at rated by
2023-07-04 16:20:12 -0500 Rating Details
2023-07-04 13:06:42 -0500 Rating Details
2023-07-04 11:31:42 -0500 Rating Details
2023-07-04 10:09:29 -0500 Rating Details
2023-07-04 09:50:46 -0500 Rating Details
2023-07-04 09:21:13 -0500 Rating Details
2023-07-04 08:44:20 -0500 Rating Details
2023-07-04 08:11:15 -0500 Rating Details
2023-07-05 02:50:29 -0500 Rating Details
2023-07-04 20:51:51 -0500 Rating Details
2023-07-04 20:36:12 -0500 Rating Details
2023-07-05 16:12:38 -0500 Rating Details
2023-07-05 14:40:50 -0500 Rating Details
2023-07-05 13:36:35 -0500 Rating Details
2023-07-05 12:57:54 -0500 Rating Details
2023-07-05 11:44:26 -0500 Rating Details
2023-07-05 11:37:14 -0500 Rating Details
2023-07-05 09:15:12 -0500 Rating Details
2023-07-05 04:57:13 -0500 Rating Details
2023-07-05 04:55:49 -0500 Rating Details
2023-07-13 06:42:59 -0500 Rating Details